Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
10.1210/er.2003-0027
Crossref journal-article
The Endocrine Society
Endocrine Reviews (80)
Bibliography

Ferrara, N. (2004). Vascular Endothelial Growth Factor: Basic Science and Clinical Progress. Endocrine Reviews, 25(4), 581–611.

Authors 1
  1. Napoleone Ferrara (first)
References 435 Referenced 2,765
  1. {'key': '2019041122205519900_R1', 'author': 'Hamilton', 'year': '1962'} by Hamilton (1962)
  2. 10.1146/annurev.cb.11.110195.000445 / Annu Rev Cell Dev Biol / Vasculogenesis. by Risau (1995)
  3. 10.1038/386671a0 / Nature / Mechanisms of angiogenesis. by Risau (1997)
  4. 10.1126/science.275.5302.964 / Science / Isolation of putative progenitor endothelial cells for angiogenesis. by Asahara (1997)
  5. 10.1006/scdb.2001.0285 / Semin Cell Dev Biol / Contribution of marrow-derived progenitors to vascular and cardiac regeneration. by Rafii (2002)
  6. 10.1038/nm871 / Nat Med / Targeting exogenous genes to tumor angiogenesis by transplantation of genetically modified hematopoietic stem cells. by De Palma (2003)
  7. 10.1126/science.1082504 / Science / Tumor response to radiotherapy regulated by endothelial cell apoptosis. by Garcia-Barros (2003)
  8. 10.1038/nm1101-1194 / Nat Med / Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. by Lyden (2001)
  9. 10.1016/S1535-6108(03)00240-X / Cancer Cell / Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. by Ruzinova (2003)
  10. 10.1038/nm0195-27 / Nat Med / Angiogenesis in cancer, vascular, rheumatoid and other disease. by Folkman (1995)
  11. {'key': '2019041122205519900_R11', 'first-page': '1625', 'author': 'Garner', 'year': '1994'} by Garner (1994)
  12. {'key': '2019041122205519900_R12', 'first-page': '11', 'article-title': 'Structural aspects of the permeability of the microvascular endothelium.', 'volume': '463', 'author': 'Palade', 'year': '1979', 'journal-title': 'Acta Physiol Scand Suppl'} / Acta Physiol Scand Suppl / Structural aspects of the permeability of the microvascular endothelium. by Palade (1979)
  13. 10.1038/nrc909 / Nat Rev Cancer / VEGF and the quest for tumour angiogenesis factors. by Ferrara (2002)
  14. 10.1038/35025215 / Nature / Vascular-specific growth factors and blood vessel formation. by Yancopoulos (2000)
  15. 10.1038/nm0603-653 / Nat Med / Angiogenesis in health and disease. by Carmeliet (2003)
  16. 10.1038/nm0603-685 / Nat Med / Molecular regulation of vessel maturation. by Jain (2003)
  17. 10.1073/pnas.88.20.9267 / Proc Natl Acad Sci USA / Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. by Maglione (1991)
  18. {'key': '2019041122205519900_R18', 'first-page': '925', 'article-title': 'Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14.', 'volume': '8', 'author': 'Maglione', 'year': '1993', 'journal-title': 'Oncogene'} / Oncogene / Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. by Maglione (1993)
  19. 10.1073/pnas.93.6.2576 / Proc Natl Acad Sci USA / Vascular endothelial growth factor B, a novel growth factor for endothelial cells. by Olofsson (1996)
  20. 10.1002/j.1460-2075.1996.tb00521.x / EMBO J / A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. by Joukov (1996)
  21. 10.1073/pnas.93.5.1988 / Proc Natl Acad Sci USA / Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. by Lee (1996)
  22. 10.1073/pnas.93.21.11675 / Proc Natl Acad Sci USA / Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family. by Orlandini (1996)
  23. 10.1073/pnas.95.2.548 / Proc Natl Acad Sci USA / Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). by Achen (1998)
  24. 10.1128/JVI.68.1.84-92.1994 / J Virol / Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. by Lyttle (1994)
  25. 10.1074/jbc.273.47.31273 / J Biol Chem / A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. by Ogawa (1998)
  26. 10.1073/pnas.96.6.3071 / Proc Natl Acad Sci USA / Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. by Wise (1999)
  27. 10.1038/ncb0102-e2 / Nat Cell Biol / Lymphatic endothelium: a new frontier of metastasis research by Karkkainen (2002)
  28. 10.1038/nrc863 / Nat Rev Cancer / Lymphangiogenesis and cancer metastasis. by Stacker (2002)
  29. 10.1210/edrv-13-1-18 / Endocr Rev / Molecular and biological properties of the vascular endothelial growth family of proteins. by Ferrara (1992)
  30. 10.1210/edrv.18.1.0287 / Endocr Rev / The biology of vascular endothelial growth factor. by Ferrara (1997)
  31. 10.2741/Ortéga / Front Biosci / Signal relays in the VEGF system by Ortega (1999)
  32. 10.1096/fasebj.13.1.9 / FASEB J / Vascular endothelial growth factor (VEGF) and its receptors. by Neufeld (1999)
  33. 10.1242/jcs.114.5.853 / J Cell Sci / The splice variants of vascular endothelial growth factor (VEGF) and their receptors. by Robinson (2001)
  34. 10.1200/JCO.2002.10.088 / J Clin Oncol / Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. by Dvorak (2002)
  35. 10.1038/nm0603-669 / Nat Med / The biology of VEGF and its receptors. by Ferrara (2003)
  36. 10.1056/NEJMoa021491 / N Engl J Med / A randomized trial of bevacizumab, an anti-VEGF antibody, for metastatic renal cancer. by Yang (2003)
  37. 10.1056/NEJMoa032691 / N Engl J Med / Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. by Hurwitz (2004)
  38. {'key': '2019041122205519900_R38', 'first-page': '891', 'article-title': 'Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber.', 'volume': '42', 'author': 'Ide', 'year': '1939', 'journal-title': 'Am J Roentgenol'} / Am J Roentgenol / Vascularization of the Brown Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. by Ide (1939)
  39. 10.1093/jnci/6.1.73 / J Natl Cancer Inst / Vascular reactions of normal and malignant tissues in vivo. I. Vascular reactions of mice to wounds and to normal and neoplastic transplants. by Algire (1945)
  40. {'key': '2019041122205519900_R40', 'first-page': '137', 'article-title': 'The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders.', 'volume': '68', 'author': 'Michaelson', 'year': '1948', 'journal-title': 'Trans Ophthalmol Soc UK'} / Trans Ophthalmol Soc UK / The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. by Michaelson (1948)
  41. {'key': '2019041122205519900_R41', 'first-page': '111', 'article-title': 'Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique.', 'volume': '41', 'author': 'Greenblatt', 'year': '1968', 'journal-title': 'J Natl Cancer Inst'} / J Natl Cancer Inst / Tumor angiogenesis: transfilter diffusion studies in the hamster by the transparent chamber technique. by Greenblatt (1968)
  42. {'key': '2019041122205519900_R42', 'first-page': '1329', 'article-title': 'Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy.', 'volume': '41', 'author': 'Ehrmann', 'year': '1968', 'journal-title': 'J Natl Cancer Inst'} / J Natl Cancer Inst / Choriocarcinoma. Transfilter stimulation of vasoproliferation in the hamster cheek pouch. Studied by light and electron microscopy. by Ehrmann (1968)
  43. 10.1056/NEJM197111182852108 / N Engl J Med / Tumor angiogenesis: therapeutic implications. by Folkman (1971)
  44. 10.1084/jem.133.2.275 / J Exp Med / Isolation of a tumor factor responsible for angiogenesis. by Folkman (1971)
  45. 10.1126/science.2432664 / Science / Angiogenic factors. by Folkman (1987)
  46. 10.1210/edrv-8-2-95 / Endocr Rev / Structural characterization and biological functions of fibroblast growth factor. by Gospodarowicz (1987)
  47. 10.1073/pnas.82.19.6409 / Proc Natl Acad Sci USA / Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. by Thomas (1985)
  48. 10.1073/pnas.82.19.6507 / Proc Natl Acad Sci USA / Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. by Esch (1985)
  49. 10.1126/science.3523756 / Science / Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization. by Jaye (1986)
  50. 10.1126/science.2425435 / Science / Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. by Abraham (1986)
  51. 10.1073/pnas.75.2.847 / Proc Natl Acad Sci USA / Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum. by Gospodarowicz (1978)
  52. 10.1073/pnas.84.8.2292 / Proc Natl Acad Sci USA / Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. by Vlodavsky (1987)
  53. 10.1073/pnas.86.24.9911 / Proc Natl Acad Sci USA / Monoclonal antibodies against heparin-binding growth factor II/basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. by Matsuzaki (1989)
  54. 10.1002/jcp.1041440112 / J Cell Physiol / Studies on the role of basic fibroblast growth factor in vivo: inability of neutralizing antibodies to block tumor growth. by Dennis (1990)
  55. 10.1128/MCB.20.6.2260-2268.2000 / Mol Cell Biol / Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. by Miller (2000)
  56. 10.1093/emboj/17.15.4213 / EMBO J / Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. by Dono (1998)
  57. {'key': '2019041122205519900_R57', 'first-page': '159', 'article-title': 'Angiogenesis. State of the art.', 'volume': '93', 'author': 'Zetter', 'year': '1988', 'journal-title': 'Chest'} / Chest / Angiogenesis. State of the art. by Zetter (1988)
  58. 10.1146/annurev.ph.53.030191.001245 / Annu Rev Physiol / Regulators of angiogenesis. by Klagsbrun (1991)
  59. 10.1126/science.6823562 / Science / Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. by Senger (1983)
  60. {'key': '2019041122205519900_R60', 'first-page': '1774', 'article-title': 'Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor.', 'volume': '50', 'author': 'Senger', 'year': '1990', 'journal-title': 'Cancer Res'} / Cancer Res / Purification and NH2-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. by Senger (1990)
  61. 10.1016/0006-291X(89)92678-8 / Biochem Biophys Res Commun / Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. by Ferrara (1989)
  62. 10.1016/S0021-9258(19)47212-8 / J Biol Chem / Human vascular permeability factor. Isolation from U937 cells. by Connolly (1989)
  63. 10.1126/science.2479986 / Science / Vascular endothelial growth factor is a secreted angiogenic mitogen. by Leung (1989)
  64. 10.1126/science.2479987 / Science / Vascular permeability factor, an endothelial cell mitogen related to PDGF. by Keck (1989)
  65. 10.1002/jcb.240470305 / J Cell Biochem / The vascular endothelial growth factor family of polypeptides. by Ferrara (1991)
  66. 10.1016/0006-291X(92)92277-5 / Biochem Biophys Res Commun / Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. by Pepper (1992)
  67. 10.1006/excr.1994.1042 / Exp Cell Res / In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. by Pepper (1994)
  68. {'key': '2019041122205519900_R68', 'first-page': '1023', 'article-title': 'Vascular endothelial growth factor, platelet-derived growth factor and indulin-like growth factor stimulate angiogenesis in vitro.', 'volume': '145', 'author': 'Nicosia', 'year': '1994', 'journal-title': 'Am J Pathol'} / Am J Pathol / Vascular endothelial growth factor, platelet-derived growth factor and indulin-like growth factor stimulate angiogenesis in vitro. by Nicosia (1994)
  69. 10.1002/j.1460-2075.1989.tb08557.x / EMBO J / Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. by Plouet (1989)
  70. {'key': '2019041122205519900_R70', 'first-page': '961', 'article-title': 'Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea.', 'volume': '8', 'author': 'Phillips', 'year': '1994', 'journal-title': 'In Vivo'} / In Vivo / Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. by Phillips (1994)
  71. 10.1161/01.RES.76.2.161 / Circ Res / Expression of vascular endothelial growth factor from a defective herpes simplex virus type 1 amplicon vector induces angiogenesis in mice. by Mesri (1995)
  72. 10.1001/archopht.1996.01100140172010 / Arch Ophthalmol / Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate. by Tolentino (1996)
  73. 10.1084/jem.20021244 / J Exp Med / Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. by Nagy (2002)
  74. 10.1016/S1097-2765(00)80426-8 / Mol Cell / CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. by Ergun (2000)
  75. 10.1038/nm1095-1024 / Nat Med / Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. by Alon (1995)
  76. 10.1074/jbc.273.21.13313 / J Biol Chem / Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. by Gerber (1998)
  77. 10.1074/jbc.273.46.30336 / J Biol Chem / VEGF regulates endothelial cell survival by the PI3-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. by Gerber (1998)
  78. 10.1172/JCI5028 / J Clin Invest / Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. by Benjamin (1999)
  79. 10.1073/pnas.93.25.14765 / Proc Natl Acad Sci USA / Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. by Yuan (1996)
  80. 10.1074/jbc.274.23.16349 / J Biol Chem / Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. by Fujio (1999)
  81. 10.1006/bbrc.1999.1589 / Biochem Biophys Res Commun / Marked induction of the IAP family antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. by Tran (1999)
  82. 10.1073/pnas.072586399 / Proc Natl Acad Sci USA / A role for survivin in chemoresistance of endothelial cells mediated by VEGF. by Tran (2002)
  83. 10.1242/dev.126.6.1149 / Development / VEGF is required for growth and survival in neonatal mice. by Gerber (1999)
  84. 10.1002/jcp.1041640219 / J Cell Physiol / Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. by Guerrin (1995)
  85. 10.1016/S0303-7207(96)03977-9 / Mol Cell Endocrinol / Effects of vascular endothelial growth factor on pancreatic duct cell replication and the insulin production of fetal islet-like cell clusters in vitro. by Oberg-Welsh (1997)
  86. 10.1523/JNEUROSCI.19-14-05731.1999 / J Neurosci / Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. by Sondell (1999)
  87. 10.1038/nm721 / Nat Med / Loss of HIF-2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. by Compernolle (2002)
  88. 10.1038/ng1211 / Nat Genet / VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. by Lambrechts (2003)
  89. 10.1084/jem.172.6.1535 / J Exp Med / Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. by Clauss (1990)
  90. 10.1016/0925-5710(95)00412-2 / Int J Hematol / Myeloid progenitor cell regulatory effects of vascular endothelial cell growth factor. by Broxmeyer (1995)
  91. 10.1038/nm1096-1096 / Nat Med / Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. by Gabrilovich (1996)
  92. 10.1182/blood.V92.11.4150 / Blood / Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. by Gabrilovich (1998)
  93. 10.1084/jem.193.9.1005 / J Exp Med / Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. by Hattori (2001)
  94. 10.1038/nature00821 / Nature / Vascular endothelial growth factor regulates hematopoietic stem cell survival by an internal autocrine loop mechanism. by Gerber (2002)
  95. 10.1016/S0092-8674(02)00676-1 / Cell / Developmental control of blood cell migration by the Drosophila VEGF pathway. by Cho (2002)
  96. 10.1093/embo-reports/kvf242 / EMBO Rep / PVF2, a PDGF/VEGF-like growth factor, induces hemocyte proliferation in Drosophila larvae. by Munier (2002)
  97. 10.1016/S1534-5807(03)00335-6 / Dev Cell / Thicker than blood: conserved mechanisms in Drosophila and vertebrate hematopoiesis. by Evans (2003)
  98. {'key': '2019041122205519900_R98', 'first-page': '1029', 'article-title': 'Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.', 'volume': '146', 'author': 'Dvorak', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. by Dvorak (1995)
  99. {'key': '2019041122205519900_R99', 'first-page': 'H2520', 'article-title': 'Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels', 'volume': '271', 'author': 'Bates', 'year': '1996', 'journal-title': 'Am J Physiol'} / Am J Physiol / Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels by Bates (1996)
  100. {'key': '2019041122205519900_R100', 'first-page': 'H687', 'article-title': 'Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway', 'volume': '273', 'author': 'Bates', 'year': '1997', 'journal-title': 'Am J Physiol'} / Am J Physiol / Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway by Bates (1997)
  101. 10.1242/jcs.108.6.2369 / J Cell Sci / Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. by Roberts (1995)
  102. 10.1083/jcb.140.4.947 / J Cell Biol / Vascular endothelial growth factor induces endothelial fenestrations in vitro. by Esser (1998)
  103. 10.1074/jbc.273.7.4220 / J Biol Chem / Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase1/2 activation in postcapillary endothelium. by Parenti (1998)
  104. 10.1172/JCI119451 / J Clin Invest / Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. by Ziche (1999)
  105. {'key': '2019041122205519900_R105', 'first-page': 'H411', 'article-title': 'Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium', 'volume': '270', 'author': 'Morbidelli', 'year': '1996', 'journal-title': 'Am J Physiol'} / Am J Physiol / Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium by Morbidelli (1996)
  106. 10.1073/pnas.041359198 / Proc Natl Acad Sci USA / Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. by Fukumura (2001)
  107. {'key': '2019041122205519900_R107', 'first-page': '673', 'article-title': 'Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing.', 'volume': '57', 'author': 'Dvorak', 'year': '1987', 'journal-title': 'Lab Invest'} / Lab Invest / Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. by Dvorak (1987)
  108. 10.1007/BF00175927 / Graefes Arch Clin Exp Ophthalmol / Immunohistochemical detection of extravasated fibrinogen (fibrin) in human diabetic retina. by Murata (1992)
  109. {'key': '2019041122205519900_R109', 'author': 'Olk', 'year': '1993'} by Olk (1993)
  110. {'key': '2019041122205519900_R110', 'first-page': '615', 'article-title': 'Vascular endothelial growth factor. The trigger for neovascularization in the eye.', 'volume': '72', 'author': 'Ferrara', 'year': '1995', 'journal-title': 'Lab Invest'} / Lab Invest / Vascular endothelial growth factor. The trigger for neovascularization in the eye. by Ferrara (1995)
  111. 10.1016/S1097-2765(00)80221-X / Mol Cell / Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. by Eliceiri (1999)
  112. 10.1016/S1535-6108(03)00168-5 / Cancer Cell / Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. by Gratton (2003)
  113. 10.1038/nm948 / Nat Med / Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. by Aicher (2003)
  114. 10.1172/JCI16929 / J Clin Invest / Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. by Lee (2003)
  115. {'key': '2019041122205519900_R115', 'first-page': 'H586', 'article-title': 'Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries', 'volume': '265', 'author': 'Ku', 'year': '1993', 'journal-title': 'Am J Physiol'} / Am J Physiol / Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries by Ku (1993)
  116. 10.1097/00005344-199606000-00011 / J Cardiovasc Pharmacol / Effects of vascular endothelial growth factor on hemodynamics and cardiac performance. by Yang (1996)
  117. 10.1161/01.CIR.0000061911.47710.8A / Circulation / The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. by Henry (2003)
  118. 10.1210/mend-5-12-1806 / Mol Endocrinol / The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. by Houck (1991)
  119. 10.1016/S0021-9258(18)99049-6 / J Biol Chem / The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. by Tischer (1991)
  120. 10.1161/01.CIR.93.8.1493 / Circulation / Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. by Vincenti (1996)
  121. 10.1074/jbc.272.11.7151 / J Biol Chem / VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. by Poltorak (1997)
  122. {'key': '2019041122205519900_R122', 'first-page': '752', 'article-title': 'Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor.', 'volume': '40', 'author': 'Jingjing', 'year': '1999', 'journal-title': 'Invest Ophthalmol Vis Sci'} / Invest Ophthalmol Vis Sci / Human Muller cells express VEGF183, a novel spliced variant of vascular endothelial growth factor. by Jingjing (1999)
  123. 10.1074/jbc.M212224200 / J Biol Chem / VEGF162, a new heparin-binding vascular endothelial growth factor splice form that is expressed in transformed human cells. by Lange (2003)
  124. {'key': '2019041122205519900_R124', 'first-page': '4123', 'article-title': 'VEGF(165)b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.', 'volume': '62', 'author': 'Bates', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / VEGF(165)b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma. by Bates (2002)
  125. 10.1016/S0021-9258(18)35712-0 / J Biol Chem / Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. by Houck (1992)
  126. 10.1073/pnas.94.14.7192 / Proc Natl Acad Sci USA / Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site. by Muller (1997)
  127. 10.1091/mbc.4.12.1317 / Mol Biol Cell / The vascular endothelial growth factor isoforms (VEGF): differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. by Park (1993)
  128. 10.1055/s-0037-1616232 / Thromb Haemost / Extracellular proteolysis and angiogenesis. by Pepper (2001)
  129. 10.1074/jbc.272.20.13390 / J Biol Chem / Extracellular cleavage of the vascular endothelial growth factor 189-amino acid form by urokinase is required for its mitogenic effect. by Plouet (1997)
  130. 10.1074/jbc.271.13.7788 / J Biol Chem / The carboxyl-terminal domain (111–165) of vascular endothelial growth factor is critical for its mitogenic potency. by Keyt (1996)
  131. 10.1128/MCB.20.19.7282-7291.2000 / Mol Cell Biol / Isoforms of vascular endothelial growth factor act in a coordinated fashion to recruit and expand tumor vasculature. by Grunstein (2000)
  132. 10.1038/8379 / Nat Med / Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. by Carmeliet (1999)
  133. 10.1101/gad.242002 / Genes Dev / Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. by Ruhrberg (2002)
  134. 10.1172/JCI200318181 / J Clin Invest / HIF hydroxylation and the mammalian oxygen-sensing pathway. by Safran (2003)
  135. 10.1152/ajpcell.2001.280.6.C1367 / Am J Physiol / Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis by Dor (2001)
  136. 10.1146/annurev.med.54.101601.152418 / Annu Rev Med / Angiogenesis in ischemic and neoplastic disorders. by Semenza (2003)
  137. 10.1016/S0021-9258(17)41787-X / J Biol Chem / Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. by Goldberg (1994)
  138. 10.1074/jbc.270.22.13333 / J Biol Chem / Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. by Levy (1995)
  139. 10.1161/01.RES.77.3.638 / Circ Res / Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. by Liu (1995)
  140. 10.1073/pnas.90.9.3928 / Proc Natl Acad Sci USA / A 24-base-pair sequence 3′ to the human erythropoietin gene contains a hypoxia-responsive transcriptional enhancer. by Madan (1993)
  141. 10.1074/jbc.270.3.1230 / J Biol Chem / Purification and characterization of hypoxia-inducible factor 1. by Wang (1995)
  142. 10.1016/S0006-2952(02)01168-1 / Biochem Pharmacol / Signal transduction to hypoxia-inducible factor 1. by Semenza (2002)
  143. 10.1073/pnas.94.9.4273 / Proc Natl Acad Sci USA / A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. by Ema (1997)
  144. 10.1080/15216540252774757 / IUBMB Life / Regulation of HIF by the von Hippel-Lindau tumour suppressor: implications for cellular oxygen sensing. by Mole (2001)
  145. 10.1016/S0140-6736(03)13643-4 / Lancet / von Hippel-Lindau disease. by Lonser (2003)
  146. {'key': '2019041122205519900_R146', 'first-page': '2299', 'article-title': 'Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein.', 'volume': '56', 'author': 'Siemeister', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein. by Siemeister (1996)
  147. 10.1073/pnas.93.20.10595 / Proc Natl Acad Sci USA / Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. by Iliopoulos (1996)
  148. 10.1016/S1097-2765(00)80096-9 / Mol Cell / The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix. by Ohh (1998)
  149. 10.1128/MCB.18.2.732 / Mol Cell Biol / Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. by Lonergan (1998)
  150. 10.1038/20459 / Nature / The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. by Maxwell (1999)
  151. 10.1126/science.1059796 / Science / Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. by Jaakkola (2001)
  152. 10.1126/science.1059817 / Science / HIF-α targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. by Ivan (2001)
  153. 10.1006/scdb.2001.0287 / Semin Cell Dev Biol / Oxygen sensors and angiogenesis. by Maxwell (2002)
  154. 10.1038/nm0603-677 / Nat Med / Regulation of angiogenesis by hypoxia: role of the HIF system. by Pugh (2003)
  155. 10.1101/gad.14.4.391 / Genes Dev / Loss of PTEN facilitates HIF-1-mediated gene expression. by Zundel (2000)
  156. 10.1126/science.275.5308.1943 / Science / PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. by Li (1997)
  157. 10.1038/ng0897-333 / Nat Genet / Germline mutations in PTEN are present in Bannayan-Zonana syndrome. by Marsh (1997)
  158. 10.1074/jbc.M302042200 / J Biol Chem / The forkhead transcription factor FOXO4 induces the down-regulation of hypoxia-inducible factor 1 α by a von Hippel-Lindau protein-independent mechanism. by Tang (2003)
  159. 10.1074/jbc.270.21.12607 / J Biol Chem / Regulation of VEGF expression in cultured keratinocytes. Implications for normal and impaired wound healing. by Frank (1995)
  160. 10.1016/S0021-9258(17)37365-9 / J Biol Chem / Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. by Pertovaara (1994)
  161. 10.1074/jbc.271.46.29483 / J Biol Chem / Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma. by Warren (1996)
  162. 10.1016/0014-5793(95)00956-A / FEBS Lett / Induction of vascular endothelial growth factor expression in synovial fibroblasts. by Ben-Av (1995)
  163. 10.1074/jbc.271.2.736 / J Biol Chem / Interleukin 6 induces the expression of vascular endothelial growth factor. by Cohen (1996)
  164. 10.1016/S0039-6060(96)80038-9 / Surgery / Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. by Soh (1996)
  165. {'key': '2019041122205519900_R165', 'first-page': '1342', 'article-title': 'Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells.', 'volume': '83', 'author': 'Shifren', 'year': '1998', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells. by Shifren (1998)
  166. 10.1172/JCI116450 / J Clin Invest / Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally-mediated angiogenesis. by Shweiki (1993)
  167. 10.1038/nm0398-336 / Nat Med / Vascular endothelial growth factor is essential for corpus luteum angiogenesis. by Ferrara (1998)
  168. {'key': '2019041122205519900_R168', 'first-page': '2135', 'article-title': 'Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles.', 'volume': '82', 'author': 'Christenson', 'year': '1997', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. by Christenson (1997)
  169. 10.1002/j.1939-4640.2004.tb02768.x / J Androl / Gonadotropin-mediated regulation of the murine VEGF expression in MA-10 Leydig cells. by Schwarzenbach (2004)
  170. 10.1097/00005392-200102000-00095 / J Urol / Vascular endothelial growth factor expression and tumor angiogenesis are regulated by androgens in hormone responsive human prostate carcinoma: evidence for androgen dependent destabilization of vascular endothelial growth factor transcripts. by Stewart (2001)
  171. 10.1073/pnas.200377097 / Proc Natl Acad Sci USA / Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors α and β. by Mueller (2000)
  172. 10.1016/S0015-0282(02)04577-6 / Fertil Steril / Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells. by Mueller (2003)
  173. 10.1074/jbc.270.43.25915 / J Biol Chem / Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. by Grugel (1995)
  174. 10.1073/pnas.95.7.3609 / Proc Natl Acad Sci USA / Impact of oncogenes in tumor angiogenesis: mutant K-ras up-regulation of vascular endothelial growth factor/vascular permeability factor is necessary, but not sufficient for tumorigenicity of human colorectal carcinoma cells. by Okada (1998)
  175. 10.1006/bbrc.1998.9966 / Biochem Biophys Res Commun / Oncogenic ras fails to restore an in vivo oncogenic phenotype in embryonic stem cells lacking VEGF. by Shi (1999)
  176. {'key': '2019041122205519900_R176', 'first-page': '6050', 'article-title': 'Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.', 'volume': '61', 'author': 'Zhang', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia. by Zhang (2001)
  177. {'key': '2019041122205519900_R177', 'first-page': '506', 'article-title': 'Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(δ716) mouse intestinal polyps.', 'volume': '62', 'author': 'Seno', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(δ716) mouse intestinal polyps. by Seno (2002)
  178. 10.1172/JCI9621 / J Clin Invest / Host cyclooxygenase-2 modulates carcinoma growth. by Williams (2000)
  179. 10.1038/nm0901-1048 / Nat Med / Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(δ 716) knockout mice. by Sonoshita (2001)
  180. 10.1084/jem.20021408 / J Exp Med / Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth. by Amano (2003)
  181. 10.1016/S0021-9258(18)45668-2 / J Biol Chem / Characterization of the receptors for vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. by Plouet (1990)
  182. 10.1016/S0021-9258(17)45395-6 / J Biol Chem / Characterization of the receptors for vascular endothelial growth factor. by Vaisman (1990)
  183. 10.1172/JCI115568 / J Clin Invest / Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. by Jakeman (1992)
  184. 10.1210/endo.133.2.7688292 / Endocrinology / Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. by Jakeman (1993)
  185. 10.1182/blood.V81.10.2767.bloodjournal81102767 / Blood / Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. by Shen (1993)
  186. {'key': '2019041122205519900_R186', 'first-page': '519', 'article-title': 'Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family.', 'volume': '8', 'author': 'Shibuya', 'year': '1990', 'journal-title': 'Oncogene'} / Oncogene / Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family. by Shibuya (1990)
  187. 10.1073/pnas.88.20.9026 / Proc Natl Acad Sci USA / A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. by Matthews (1991)
  188. {'key': '2019041122205519900_R188', 'first-page': '1677', 'article-title': 'Identification of a new endothelial cell growth factor receptor tyrosine kinase.', 'volume': '6', 'author': 'Terman', 'year': '1991', 'journal-title': 'Oncogene'} / Oncogene / Identification of a new endothelial cell growth factor receptor tyrosine kinase. by Terman (1991)
  189. {'key': '2019041122205519900_R189', 'first-page': '5738', 'article-title': 'FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.', 'volume': '52', 'author': 'Pajusola', 'year': '1992', 'journal-title': 'Cancer Res'} / Cancer Res / FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. by Pajusola (1992)
  190. 10.1126/science.1312256 / Science / The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. by de Vries (1992)
  191. 10.1074/jbc.272.38.23659 / J Biol Chem / Differential transcriptional regulation of the two VEGF receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. by Gerber (1997)
  192. 10.1016/S0021-9258(18)47298-5 / J Biol Chem / Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. by Park (1994)
  193. 10.1073/pnas.95.20.11709 / Proc Natl Acad Sci USA / Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. by Olofsson (1998)
  194. 10.1073/pnas.90.22.10705 / Proc Natl Acad Sci USA / Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. by Kendall (1993)
  195. 10.1002/j.1460-2075.1996.tb00872.x / EMBO J / The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. by Davis-Smyth (1996)
  196. 10.1074/jbc.272.16.10382 / J Biol Chem / Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1. by Barleon (1997)
  197. 10.1074/jbc.273.6.3216 / J Biol Chem / Mapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stability. by Davis-Smyth (1998)
  198. 10.1016/S0092-8674(00)80456-0 / Cell / Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. by Wiesmann (1997)
  199. 10.1016/S0021-9258(18)47116-5 / J Biol Chem / Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. by Waltenberger (1994)
  200. 10.1038/87904 / Nat Med / Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. by Carmeliet (2001)
  201. 10.1093/emboj/19.15.4064 / EMBO J / A repressor sequence in the juxtamembrane domain of Flt-1 (VEGFR-1) constitutively inhibits VEGF-dependent PI 3 kinase activation and endothelial cell migration. by Gille (2000)
  202. 10.1074/jbc.M103213200 / J Biol Chem / Vascular permeability factor (VPF)/vascular endothelial growth factor (VEGF) peceptor-1 down-modulates VPF/VEGF receptor-2-mediated endothelial cell proliferation, but not migration, through phosphatidylinositol 3-kinase-dependent pathways. by Zeng (2001)
  203. 10.1038/sj.onc.1201545 / Oncogene / Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-γ and migration of endothelial cells expressing Flt 1. by Landgren (1998)
  204. 10.1038/sj.onc.1201786 / Oncogene / Flt-1, a receptor for vascular endothelial growth factor, has transforming and morphogenic potentials. by Maru (1998)
  205. 10.1038/nm884 / Nat Med / Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. by Autiero (2003)
  206. 10.1074/jbc.M313237200 / J Biol Chem / The crystal structure of PlGF in complex with domain 2 of VEGFR-1. by Christinger (2004)
  207. 10.1038/376066a0 / Nature / Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. by Fong (1995)
  208. 10.1242/dev.126.13.3015 / Development / Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. by Fong (1999)
  209. 10.1073/pnas.95.16.9349 / Proc Natl Acad Sci USA / Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. by Hiratsuka (1998)
  210. 10.1182/blood.V87.8.3336.bloodjournal8783336 / Blood / Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. by Barleon (1996)
  211. 10.1182/blood-2002-11-3423 / Blood / Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. by Selvaraj (2003)
  212. {'key': '2019041122205519900_R212', 'first-page': '1207', 'article-title': 'Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.', 'volume': '61', 'author': 'Hiratsuka', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. by Hiratsuka (2001)
  213. 10.1016/S1535-6108(02)00153-8 / Cancer Cell / MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. by Hiratsuka (2002)
  214. 10.1038/nm740 / Nat Med / Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. by Hattori (2002)
  215. 10.1038/nm731 / Nat Med / Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. by Luttun (2002)
  216. 10.1161/01.RES.0000057997.77714.72 / Circ Res / VEGFR-1-selective VEGF homologue PlGF is arteriogenic: evidence for a monocyte-mediated mechanism. by Pipp (2003)
  217. 10.1126/science.1079562 / Science / Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. by LeCouter (2003)
  218. 10.1126/science.1063889 / Science / Liver organogenesis promoted by endothelial cells prior to vascular function. by Matsumoto (2001)
  219. 10.1126/science.1064344 / Science / Induction of pancreatic differentiation by signals from blood vessels. by Lammert (2001)
  220. 10.1016/0006-291X(92)90483-2 / Biochem Biophys Res Commun / Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. by Terman (1992)
  221. 10.1073/pnas.90.16.7533 / Proc Natl Acad Sci USA / Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. by Quinn (1993)
  222. 10.1016/0092-8674(93)90573-9 / Cell / High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. by Millauer (1993)
  223. 10.1038/376062a0 / Nature / Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. by Shalaby (1995)
  224. 10.1242/dev.124.10.2039 / Development / Flk-1 expression defines a population of early embryonic hematopoietic precursors. by Kabrun (1997)
  225. 10.1074/jbc.273.18.11197 / J Biol Chem / Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. by Fuh (1998)
  226. {'key': '2019041122205519900_R226', 'first-page': '1', 'article-title': 'VEGF receptor signal transduction.', 'volume': '21', 'author': 'Matsumoto', 'year': '2001', 'journal-title': 'Sci STKE 112 RE'} / Sci STKE 112 RE / VEGF receptor signal transduction. by Matsumoto (2001)
  227. 10.1093/emboj/20.11.2768 / EMBO J / A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells. by Takahashi (2001)
  228. 10.1074/jbc.270.12.6729 / J Biol Chem / Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. by Guo (1995)
  229. {'key': '2019041122205519900_R229', 'first-page': '851', 'article-title': 'A mechanism for modulation of cellular responses to VEGF: activation of the integrins.', 'volume': '6', 'author': 'Byzova', 'year': '2000', 'journal-title': 'Mol Cell'} / Mol Cell / A mechanism for modulation of cellular responses to VEGF: activation of the integrins. by Byzova (2000)
  230. 10.1038/sj.onc.1202527 / Oncogene / VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. by Takahashi (1999)
  231. 10.1074/jbc.275.7.5096 / J Biol Chem / Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. by Wu (2000)
  232. 10.1074/jbc.M002016200 / J Biol Chem / Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific VEGF mutants. by Gille (2001)
  233. 10.1074/jbc.C300454200 / J Biol Chem / Snake venom VEGFs exhibit potent activity through their specific recognition of KDR (VEGF receptor 2). by Yamazaki (2003)
  234. 10.1161/01.RES.86.8.892 / Circ Res / Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. by Morales-Ruiz (2000)
  235. {'key': '2019041122205519900_R235', 'first-page': '2749', 'article-title': 'Placental growth factor is a survival factor for tumor endothelial cells and macrophages.', 'volume': '62', 'author': 'Adini', 'year': '2002', 'journal-title': 'Cancer Res'} / Cancer Res / Placental growth factor is a survival factor for tumor endothelial cells and macrophages. by Adini (2002)
  236. 10.1074/jbc.271.10.5761 / J Biol Chem / Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. by Soker (1996)
  237. 10.1016/S0092-8674(00)81402-6 / Cell / Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. by Soker (1998)
  238. 10.1016/S1050-1738(01)00140-2 / Trends Cardiovas Med / The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. by Neufeld (2002)
  239. 10.1016/S0021-9258(19)61431-6 / J Biol Chem / The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. by Fuh (2000)
  240. {'key': '2019041122205519900_R240', 'first-page': '233', 'article-title': 'Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165.', 'volume': '146', 'author': 'Miao', 'year': '1999', 'journal-title': 'J Cell Biol'} / J Cell Biol / Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. by Miao (1999)
  241. 10.1016/S0092-8674(00)80063-X / Cell / Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. by Tamagnone (1999)
  242. 10.1007/978-1-4615-0119-0_2 / Adv Exp Med Biol / Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. by Bagri (2002)
  243. 10.1242/dev.126.21.4895 / Development / A requirement for neuropilin-1 in embryonic vessel formation. by Kawasaki (1999)
  244. 10.1073/pnas.162366299 / Proc Natl Acad Sci USA / Neuropilin-1 is required for vascular development and is a mediator of VEGF-dependent angiogenesis in zebrafish. by Lee (2002)
  245. 10.1242/dev.129.20.4797 / Development / Abnormal lymphatic vessel development in neuropilin 2 mutant mice. by Yuan (2002)
  246. 10.1038/380435a0 / Nature / Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. by Carmeliet (1996)
  247. 10.1038/380439a0 / Nature / Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. by Ferrara (1996)
  248. 10.1016/S0012-1606(03)00356-7 / Dev Biol / Cortical and retinal defects caused by dosage-dependent reductions in VEGF-A paracrine signaling. by Haigh (2003)
  249. 10.1160/TH03-09-0582 / Thromb Haemost / Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. by Raab (2004)
  250. 10.1242/dev.127.18.3941 / Development / Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. by Miquerol (2000)
  251. 10.1161/01.RES.86.2.e29 / Circ Res / Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia by Bellomo (2000)
  252. 10.1038/ni1013 / Nat Immunol / Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. by Karkkainen (2004)
  253. 10.1172/JCI119416 / J Clin Invest / Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis. by Kitamoto (1997)
  254. 10.1172/JCI17423 / J Clin Invest / Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. by Eremina (2003)
  255. 10.1172/JCI6740 / J Clin Invest / VEGF(165) mediates glomerular endothelial repair. by Ostendorf (1999)
  256. 10.1074/jbc.C300012200 / J Biol Chem / Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. by Sugimoto (2003)
  257. 10.1177/019262339902700115 / Toxicol Pathol / Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. by Ryan (1999)
  258. 10.1200/JCO.2003.10.066 / J Clin Oncol / Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. by Kabbinavar (2003)
  259. {'key': '2019041122205519900_R259', 'first-page': '179', 'author': 'Poole', 'year': '1991'} by Poole (1991)
  260. 10.1038/9467 / Nat Med / VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. by Gerber (1999)
  261. 10.1242/jcs.113.1.59 / J Cell Sci / Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. by Carlevaro (2000)
  262. 10.1210/endo.143.4.8719 / Endocrinology / Bone morphogenetic proteins stimulate angiogenesis through osteoblast-derived vascular endothelial growth factor A. by Deckers (2002)
  263. 10.1097/00006534-200206000-00033 / Plast Reconstr Surg / Hypoxia and VEGF up-regulate BMP-2 mRNA and protein expression in microvascular endothelial cells: implications for fracture healing. by Bouletreau (2002)
  264. 10.1016/S0092-8674(00)81169-1 / Cell / MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. by Vu (1998)
  265. 10.1038/35036374 / Nat Cell Biol / Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. by Bergers (2000)
  266. 10.1073/pnas.152324099 / Proc Natl Acad Sci USA / Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. by Street (2002)
  267. 10.1242/dev.00559 / Development / Altered fracture repair in the absence of MMP9. by Colnot (2003)
  268. 10.1016/S8756-3282(01)00690-1 / Bone / Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. by Mayr-Wohlfart (2002)
  269. 10.1083/jcb.151.4.879 / J Cell Biol / Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. by Engsig (2000)
  270. 10.1016/S1359-6446(03)02866-6 / Drug Discov Today / Angiogenesis and bone repair. by Carano (2003)
  271. 10.1242/dev.127.7.1445 / Development / Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. by Haigh (2000)
  272. 10.1242/dev.129.8.1893 / Development / Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis. by Zelzer (2002)
  273. 10.1002/aja.1000730206 / Am J Anat / The changes in the vascular pattern of the ovary of the albino rat during the estrous cycle. by Bassett (1943)
  274. 10.1210/endo-109-2-356 / Endocrinology / Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. by Zeleznik (1981)
  275. 10.1016/S0015-0282(16)46511-8 / Fertil Steril / The role of lipoproteins in the regulation of progesterone secretion by the corpus luteum. by Carr (1981)
  276. {'key': '2019041122205519900_R276', 'first-page': '1385', 'article-title': 'Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis.', 'volume': '78', 'author': 'Goede', 'year': '1998', 'journal-title': 'Lab Invest'} / Lab Invest / Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. by Goede (1998)
  277. 10.1126/science.277.5322.55 / Science / Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. by Maisonpierre (1997)
  278. 10.1210/endo-127-2-965 / Endocrinology / Vascular endothelial growth factor is expressed in rat corpus luteum. by Phillips (1990)
  279. 10.1210/endo.131.1.1612003 / Endocrinology / Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. by Ravindranath (1992)
  280. {'key': '2019041122205519900_R280', 'first-page': '768', 'article-title': 'Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey.', 'volume': '86', 'author': 'Zimmermann', 'year': '2001', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. by Zimmermann (2001)
  281. 10.1006/mvre.2001.2312 / Microvasc Res / Preovulatory treatment of mice with anti-VEGF receptor 2 antibody inhibits angiogenesis in corpora lutea. by Zimmermann (2001)
  282. 10.1210/endo.141.3.7369 / Endocrinology / Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. by Fraser (2000)
  283. 10.1095/biolreprod67.4.1305 / Biol Reprod / Injection of soluble vascular endothelial growth factor receptor 1 into the preovulatory follicle disrupts ovulation and subsequent luteal function in rhesus monkeys. by Hazzard (2002)
  284. 10.1095/biolreprod67.4.1180 / Biol Reprod / Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. by Rowe (2002)
  285. 10.1038/35091000 / Nature / Identification of an angiogenic mitogen selective for endocrine gland endothelium. by LeCouter (2001)
  286. 10.1038/nm0902-913 / Nat Med / Endocrine gland-derived VEGF and the emerging hypothesis of organ-specific regulation of angiogenesis. by LeCouter (2002)
  287. 10.1038/sj.embor.embor830 / EMBO Rep / The AVIT protein family. by Kaser (2003)
  288. 10.1016/S0002-9440(10)64322-2 / Am J Pathol / Differential expression of the angiogenic factor genes VEGF and EG-VEGF in normal and polycystic human ovaries. by Ferrara (2003)
  289. 10.1210/en.2002-0146 / Endocrinology / Mouse endocrine-gland derived vascular endothelial growth factor. A distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. by LeCouter (2003)
  290. 10.1016/0092-8674(94)90211-9 / Cell / A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. by Luo (1994)
  291. 10.1073/pnas.92.24.10939 / Proc Natl Acad Sci USA / Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. by Sadovsky (1995)
  292. 10.1210/rp.57.1.19 / Recent Prog Horm Res / Steroidogenic factor 1: an essential mediator of endocrine development. by Parker (2002)
  293. 10.1177/107155769400100402 / J Soc Gynecol Investig / Strategies of ovarian function of importance to gynecologic investigations. by Lasley (1994)
  294. 10.1258/0007142001903364 / Br Med Bull / Angiogenesis and its control in the female reproductive system. by Fraser (2000)
  295. 10.1016/S0960-9822(03)00378-6 / Curr Biol / Role of VEGF-A in vascularization of pancreatic islets. by Lammert (2003)
  296. {'key': '2019041122205519900_R296', 'first-page': '99', 'article-title': 'Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro.', 'volume': '17', 'author': 'Volm', 'year': '1997', 'journal-title': 'Anticancer Res'} / Anticancer Res / Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro. by Volm (1997)
  297. 10.1002/(SICI)1097-0215(19970220)74:1<64::AID-IJC11>3.0.CO;2-I / Int J Cancer / Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. by Volm (1997)
  298. 10.1016/0046-8177(95)90119-1 / Hum Pathol / Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. by Brown (1995)
  299. {'key': '2019041122205519900_R299', 'first-page': '2013', 'article-title': 'Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer.', 'volume': '56', 'author': 'Yoshiji', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. by Yoshiji (1996)
  300. {'key': '2019041122205519900_R300', 'first-page': '4727', 'article-title': 'Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.', 'volume': '53', 'author': 'Brown', 'year': '1993', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. by Brown (1993)
  301. {'key': '2019041122205519900_R301', 'first-page': '3004', 'article-title': 'Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma.', 'volume': '56', 'author': 'Suzuki', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. by Suzuki (1996)
  302. 10.1016/S0959-8049(97)10068-5 / Eur J Cancer / Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. by Ellis (1998)
  303. 10.1038/bjc.1998.281 / Br J Cancer / In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis. by Uchida (1998)
  304. {'key': '2019041122205519900_R304', 'first-page': '1255', 'article-title': 'Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.', 'volume': '143', 'author': 'Brown', 'year': '1993', 'journal-title': 'Am J Pathol'} / Am J Pathol / Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. by Brown (1993)
  305. 10.1016/S0022-5347(01)65028-6 / J Urol / Vascular endothelial growth factor expression is increased in renal cell carcinoma. by Nicol (1997)
  306. 10.1016/S0959-8049(98)00278-0 / Eur J Cancer / Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. by Tomisawa (1999)
  307. {'key': '2019041122205519900_R307', 'first-page': '276', 'article-title': 'Vascular permeability factor gene expression in normal and neoplastic human ovaries.', 'volume': '54', 'author': 'Olson', 'year': '1994', 'journal-title': 'Cancer Res'} / Cancer Res / Vascular permeability factor gene expression in normal and neoplastic human ovaries. by Olson (1994)
  308. {'key': '2019041122205519900_R308', 'first-page': '607', 'article-title': 'Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.', 'volume': '77', 'author': 'Sowter', 'year': '1997', 'journal-title': 'Lab Invest'} / Lab Invest / Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. by Sowter (1997)
  309. 10.1038/bjc.1997.537 / Br J Cancer / Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. by Yamamoto (1997)
  310. 10.1002/(SICI)1097-0142(19960801)78:3<454::AID-CNCR12>3.0.CO;2-Y / Cancer / Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma. by Guidi (1996)
  311. 10.1038/359843a0 / Nature / Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. by Shweiki (1992)
  312. 10.1038/359845a0 / Nature / Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. by Plate (1992)
  313. {'key': '2019041122205519900_R313', 'first-page': '913', 'article-title': 'Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: association with regions of necrosis.', 'volume': '2', 'author': 'Phillips', 'year': '1993', 'journal-title': 'Int J Oncol'} / Int J Oncol / Intense focal expression of vascular endothelial growth factor mRNA in human intracranial neoplasms: association with regions of necrosis. by Phillips (1993)
  314. 10.1172/JCI116165 / J Clin Invest / Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. by Berkman (1993)
  315. {'key': '2019041122205519900_R315', 'first-page': '1358', 'article-title': 'Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.', 'volume': '155', 'author': 'Wizigmann Voos', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. by Wizigmann Voos (1995)
  316. 10.1007/BF02738884 / Endocr Pathol / Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. by Lloyd (1999)
  317. {'key': '2019041122205519900_R317', 'first-page': '3741', 'article-title': 'Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid.', 'volume': '82', 'author': 'Soh', 'year': '1997', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. by Soh (1997)
  318. 10.1210/jcem.86.2.7226 / J Clin Endocrinol Metab / Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. by Klein (2001)
  319. 10.1210/er.2002-0008 / Endocr Rev / Angiogenesis in endocrine tumors. by Turner (2003)
  320. 10.1038/362841a0 / Nature / Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. by Kim (1993)
  321. 10.1172/JCI117857 / J Clin Invest / Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. by Warren (1995)
  322. {'key': '2019041122205519900_R322', 'first-page': '921', 'article-title': 'Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth.', 'volume': '56', 'author': 'Melnyk', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Vascular endothelial growth factor promotes tumor dissemination by a mechanism distinct from its effect on primary tumor growth. by Melnyk (1996)
  323. {'key': '2019041122205519900_R323', 'first-page': '5296', 'article-title': 'Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121.', 'volume': '55', 'author': 'Asano', 'year': '1995', 'journal-title': 'Cancer Res'} / Cancer Res / Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121. by Asano (1995)
  324. {'key': '2019041122205519900_R324', 'first-page': '4032', 'article-title': 'Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy.', 'volume': '56', 'author': 'Borgstrom', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy. by Borgstrom (1996)
  325. 10.1002/(SICI)1097-0045(19980401)35:1<1::AID-PROS1>3.0.CO;2-O / Prostate / Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. by Borgstrom (1998)
  326. 10.1016/S0002-9440(10)65669-6 / Am J Pathol / Role of vascular endothelial growth factor in ovarian cancer: inhibition of ascites formation by immunoneutralization. by Mesiano (1998)
  327. {'key': '2019041122205519900_R327', 'first-page': '4203', 'article-title': 'Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin.', 'volume': '19', 'author': 'Borgstrom', 'year': '1999', 'journal-title': 'Anticancer Res'} / Anticancer Res / Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin. by Borgstrom (1999)
  328. 10.1038/367576a0 / Nature / Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. by Millauer (1994)
  329. {'key': '2019041122205519900_R329', 'first-page': '3540', 'article-title': 'Flk-1 as a target for tumor growth inhibition.', 'volume': '56', 'author': 'Strawn', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Flk-1 as a target for tumor growth inhibition. by Strawn (1996)
  330. {'key': '2019041122205519900_R330', 'first-page': '2178', 'article-title': 'PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.', 'volume': '60', 'author': 'Wood', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. by Wood (2000)
  331. {'key': '2019041122205519900_R331', 'first-page': '970', 'article-title': 'ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy.', 'volume': '60', 'author': 'Wedge', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. by Wedge (2000)
  332. {'key': '2019041122205519900_R332', 'first-page': '393', 'article-title': 'Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.', 'volume': '56', 'author': 'Saleh', 'year': '1996', 'journal-title': 'Cancer Res'} / Cancer Res / Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. by Saleh (1996)
  333. {'key': '2019041122205519900_R333', 'first-page': '4185', 'article-title': 'Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.', 'volume': '58', 'author': 'Oku', 'year': '1998', 'journal-title': 'Cancer Res'} / Cancer Res / Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts. by Oku (1998)
  334. {'key': '2019041122205519900_R334', 'first-page': '5209', 'article-title': 'Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis.', 'volume': '59', 'author': 'Prewett', 'year': '1999', 'journal-title': 'Cancer Res'} / Cancer Res / Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis. by Prewett (1999)
  335. 10.1089/hum.1998.9.6-823 / Hum Gene Ther / Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. by Kong (1998)
  336. 10.1073/pnas.95.15.8795 / Proc Natl Acad Sci USA / Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. by Goldman (1998)
  337. {'key': '2019041122205519900_R337', 'first-page': '6253', 'article-title': 'Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor.', 'volume': '60', 'author': 'Gerber', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Complete inhibition of rhabdomyosarcoma xenograft growth and neovascularization requires blockade of both tumor and host vascular endothelial growth factor. by Gerber (2000)
  338. 10.1073/pnas.081615298 / Proc Natl Acad Sci USA / Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. by Kuo (2001)
  339. 10.1073/pnas.172398299 / Proc Natl Acad Sci USA / VEGF-Trap: a VEGF blocker with potent antitumor effects. by Holash (2002)
  340. 10.1067/msy.2000.110430 / Surgery / Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo. by Soh (2000)
  341. 10.1210/en.2003-1228 / Endocrinology / Effects of PTK787/ZK222584 a tyrosine kinase inhibitor on the growth of a poorly differentiated thyroid carcinoma. An animal study. by Schoenberger (2003)
  342. 10.1016/S0092-8674(00)81731-6 / Cell / Tumor induction of VEGF promoter activity in stromal cells. by Fukumura (1998)
  343. {'key': '2019041122205519900_R343', 'first-page': '6248', 'article-title': 'Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α→hypoxia response element→ VEGF cascade differentially regulates vascular response and growth rate in tumors.', 'volume': '60', 'author': 'Tsuzuki', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1α→hypoxia response element→ VEGF cascade differentially regulates vascular response and growth rate in tumors. by Tsuzuki (2000)
  344. 10.1016/S0002-9440(10)64522-1 / Am J Pathol / In vivo detection of human vascular endothelial growth factor promoter activity in transgenic mouse skin. by Kishimoto (2000)
  345. 10.1016/S1535-6108(02)00031-4 / Cancer Cell / VEGF-A has a critical, nonredundant role in angiogenic switching and pancreatic β cell carcinogenesis. by Inoue (2002)
  346. 10.1038/nrc1093 / Nat Rev Cancer / Tumorigenesis and the angiogenic switch. by Bergers (2003)
  347. 10.1172/JCI8829 / J Clin Invest / Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity by Klement (2000)
  348. {'key': '2019041122205519900_R348', 'first-page': '5565', 'article-title': 'Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.', 'volume': '60', 'author': 'Lee', 'year': '2000', 'journal-title': 'Cancer Res'} / Cancer Res / Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. by Lee (2000)
  349. {'key': '2019041122205519900_R349', 'first-page': '39', 'article-title': 'Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.', 'volume': '61', 'author': 'Kozin', 'year': '2001', 'journal-title': 'Cancer Res'} / Cancer Res / Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. by Kozin (2001)
  350. 10.1038/nm0901-987 / Nat Med / Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. by Jain (2001)
  351. 10.3109/07357909809039771 / Cancer Invest / Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. by Pham (1998)
  352. 10.1038/nm988 / Nat Med / Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. by Willett (2004)
  353. {'key': '2019041122205519900_R353', 'first-page': '4593', 'article-title': 'Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders.', 'volume': '57', 'author': 'Presta', 'year': '1997', 'journal-title': 'Cancer Res'} / Cancer Res / Humanization of an anti-VEGF monoclonal antibody for the therapy of solid tumors and other disorders. by Presta (1997)
  354. 10.1007/s00109-002-0397-4 / J Mol Med / The role of VEGF in normal and neoplastic hematopoiesis. by Gerber (2003)
  355. 10.1182/blood.V97.5.1413 / Blood / The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts. by Smolich (2001)
  356. 10.1172/JCI8978 / J Clin Invest / Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration. by Dias (2000)
  357. 10.1182/blood-2002-10-2998 / Blood / A phase II clinical study of SU5416 in patients with refractory acute myeloid leukemia. by Fiedler (2003)
  358. {'key': '2019041122205519900_R358', 'first-page': '1133', 'article-title': 'Studies on retinal neovascularization.', 'volume': '19', 'author': 'Patz', 'year': '1980', 'journal-title': 'Invest Ophthalmol Vis Sci'} / Invest Ophthalmol Vis Sci / Studies on retinal neovascularization. by Patz (1980)
  359. 10.1523/JNEUROSCI.15-07-04738.1995 / J Neurosci / Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. by Stone (1995)
  360. 10.1242/dev.125.9.1591 / Development / A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. by Benjamin (1998)
  361. 10.1126/science.277.5323.242 / Science / Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. by Lindhal (1997)
  362. {'key': '2019041122205519900_R362', 'first-page': '574', 'article-title': 'Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.', 'volume': '145', 'author': 'Miller', 'year': '1994', 'journal-title': 'Am J Pathol'} / Am J Pathol / Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. by Miller (1994)
  363. 10.1001/archopht.1996.01100140419009 / Arch Ophthalmol / Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity. by Pierce (1996)
  364. 10.1056/NEJM199412013312203 / N Engl J Med / Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. by Aiello (1994)
  365. 10.1001/archopht.1994.01090230090028 / Arch Ophthalmol / Detection of vascular endothelial growth factor mRNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. by Malecaze (1994)
  366. 10.1073/pnas.92.23.10457 / Proc Natl Acad Sci USA / Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. by Aiello (1995)
  367. 10.1001/archopht.1996.01100130062010 / Arch Ophthalmol / Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. by Adamis (1996)
  368. 10.1073/pnas.93.10.4851 / Proc Natl Acad Sci USA / Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. by Robinson (1996)
  369. 10.1016/S0002-9440(10)64773-6 / Am J Pathol / Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. by Ozaki (2000)
  370. 10.1073/pnas.022644499 / Proc Natl Acad Sci USA / Characterization of protein kinase C β isoform’s action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization. by Suzuma (2002)
  371. {'key': '2019041122205519900_R371', 'first-page': '855', 'article-title': 'Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes.', 'volume': '37', 'author': 'Lopez', 'year': '1996', 'journal-title': 'Invest Ophthalmol Vis Sci'} / Invest Ophthalmol Vis Sci / Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. by Lopez (1996)
  372. 10.1038/sj.onc.1206773 / Oncogene / Ocular neovascularization: a valuable model system. by Campochiaro (2003)
  373. 10.1006/jmbi.1999.3192 / J Mol Biol / Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. by Chen (1999)
  374. 10.1074/jbc.273.32.20556 / J Biol Chem / 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. by Ruckman (1998)
  375. 10.1001/archopht.120.3.338 / Arch Ophthalmol / Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. by Krzystolik (2002)
  376. 10.1128/JVI.75.20.9828-9835.2001 / J Virol / Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. by Zheng (2001)
  377. 10.1111/1523-1747.ep12312542 / J Invest Dermatol / Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. by Detmar (1995)
  378. 10.1046/j.1523-1747.1998.00262.x / J Invest Dermatol / Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. by Detmar (1998)
  379. 10.1016/S0092-8674(03)00154-5 / Cell / HIF1α is essential for myeloid cell-mediated inflammation. by Cramer (2003)
  380. 10.4049/jimmunol.152.8.4149 / J Immunol / Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. by Koch (1994)
  381. 10.1084/jem.180.1.341 / J Exp Med / Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. by Fava (1994)
  382. 10.1038/labinvest.3780127 / Lab Invest / Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. by Miotla (2000)
  383. 10.1006/bbrc.2001.4395 / Biochem Biophys Res Commun / Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. by Sone (2001)
  384. 10.1038/sj.gt.3302104 / Gene Ther / Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis. by Afuwape (2003)
  385. 10.4049/jimmunol.168.11.5824 / J Immunol / Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. by Matsumoto (2002)
  386. 10.1046/j.1538-7836.2003.00263.x / J Thromb Haemost / Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders. by Autiero (2003)
  387. 10.1182/blood-2002-05-1516 / Blood / A critical role of placental growth factor in the induction of inflammation and edema formation. by Oura (2003)
  388. 10.1172/JCI17712 / J Clin Invest / Proinflammatory functions of vascular endothelial growth factor in alloimmunity. by Reinders (2003)
  389. 10.1152/ajpcell.1993.264.4.C995 / Am J Physiol / Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues by Monacci (1993)
  390. 10.1161/01.STR.27.10.1865 / Stroke / VEGF and flt. Expression time kinetics in rat brain infarct. by Kovacs (1996)
  391. 10.1161/01.STR.28.10.2039 / Stroke / Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. by Hayashi (1997)
  392. 10.1097/00005072-199809000-00009 / J Neuropathol Exp Neurol / Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat. by Lennmyr (1998)
  393. 10.1172/JCI8218 / J Clin Invest / VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. by van Bruggen (1999)
  394. 10.1038/84675 / Nat Med / Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. by Paul (2001)
  395. 10.1172/JCI200317977 / J Clin Invest / VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. by Sun (2003)
  396. 10.1007/s00701-002-1035-1 / Acta Neurochir (Wien) / Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume. by Harrigan (2003)
  397. 10.1210/jcem-22-3-325 / J Clin Endocrinol Metab / The polycystic ovary. I. Clinical and histologic features. by Goldzieher (1962)
  398. {'key': '2019041122205519900_R398', 'first-page': '1117', 'author': 'Yen', 'year': '1996'} by Yen (1996)
  399. 10.1111/j.1365-2265.1994.tb01818.x / Clin Endocrinol (Oxf) / Ovarian stromal hypertrophy in hyperandrogenic women. by Dewailly (1994)
  400. 10.1016/S0015-0282(01)01919-7 / Fertil Steril / A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. by Fulghesu (2001)
  401. 10.1146/annurev.med.52.1.401 / Annu Rev Med / Current concepts in the polycystic ovary syndrome. by Dunaif (2001)
  402. 10.1016/S0015-0282(00)00684-1 / Fertil Steril / Effects of laparoscopic ovarian drilling on serum vascular endothelial growth factor and on insulin responses to the oral glucose tolerance test in women with polycystic ovary syndrome. by Tulandi (2000)
  403. 10.1093/humrep/13.3.651 / Hum Reprod / Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. by Agrawal (1998)
  404. {'key': '2019041122205519900_R404', 'first-page': '157', 'article-title': 'Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development.', 'volume': '146', 'author': 'Kamat', 'year': '1995', 'journal-title': 'Am J Pathol'} / Am J Pathol / Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. by Kamat (1995)
  405. 10.1016/S0140-6736(94)93001-5 / Lancet / Vascular endothelial growth factor as a capillary permeability agent in ovarian hyperstimulation syndrome. by McClure (1994)
  406. 10.1172/JCI4814 / J Clin Invest / Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. by Levin (1998)
  407. 10.1016/0002-9378(72)90180-9 / Am J Obstet Gynecol / Ovarian hyperstimulation syndrome: report of one case with notes on pathogenesis and treatment. by Engel (1972)
  408. {'key': '2019041122205519900_R408', 'first-page': '220', 'article-title': 'Pathophysiology of the ovarian hyperstimulation syndrome.', 'volume': '166', 'author': 'Haning', 'year': '1985', 'journal-title': 'Obstet Gynecol'} / Obstet Gynecol / Pathophysiology of the ovarian hyperstimulation syndrome. by Haning (1985)
  409. 10.1016/0002-9378(81)90675-X / Am J Obstet Gynecol / Induction of ovulation with menotropins in women with polycystic ovary syndrome. by Kemmann (1981)
  410. 10.1677/jme.0.0200363 / J Mol Endocrinol / The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. by Kobayashi (1998)
  411. 10.1172/JCI118815 / J Clin Invest / Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. by McLaren (1996)
  412. {'key': '2019041122205519900_R412', 'first-page': '3112', 'article-title': 'Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.', 'volume': '81', 'author': 'Shifren', 'year': '1996', 'journal-title': 'J Clin Endocrinol Metab'} / J Clin Endocrinol Metab / Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. by Shifren (1996)
  413. 10.1210/jc.2002-021912 / J Clin Endocrinol Metab / Antiangiogenic agents are effective inhibitors of endometriosis. by Hull (2003)
  414. 10.1172/JCI17189 / J Clin Invest / Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. by Maynard (2003)
  415. 10.1056/NEJMoa031884 / N Engl J Med / Circulating angiogenic factors and the risk of preeclampsia. by Levine (2004)
  416. {'key': '2019041122205519900_R416', 'first-page': 'Mosby', 'article-title': 'Interventional treatment of peripheral vascular disease', 'volume': 'Louis', 'author': 'Graor', 'year': '1991', 'journal-title': 'St.'} / St. / Interventional treatment of peripheral vascular disease by Graor (1991)
  417. 10.1172/JCI117018 / J Clin Invest / Therapeutic angiogenesis: a single intra-arterial bolus of vascular endothelial growth factor augments collateral vessel formation in a rabbit ischemic hind-limb model. by Takeshita (1994)
  418. {'key': '2019041122205519900_R418', 'first-page': '487', 'article-title': 'Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo.', 'volume': '75', 'author': 'Takeshita', 'year': '1996', 'journal-title': 'Lab Invest'} / Lab Invest / Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. by Takeshita (1996)
  419. 10.1006/bbrc.1996.1556 / Biochem Biophys Res Commun / Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. by Takeshita (1996)
  420. 10.1161/01.CIR.91.11.2802 / Circulation / Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. by Bauters (1995)
  421. 10.1016/S0741-5214(98)70236-8 / J Vasc Surg / Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. by Mack (1998)
  422. 10.1038/74664 / Nat Med / Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. by Schratzberger (2000)
  423. {'key': '2019041122205519900_R423', 'first-page': 'H1791', 'article-title': 'Vascular endothelial growth factor administration in chronic myocardial ischemia', 'volume': '270', 'author': 'Harada', 'year': '1996', 'journal-title': 'Am J Physiol'} / Am J Physiol / Vascular endothelial growth factor administration in chronic myocardial ischemia by Harada (1996)
  424. 10.1016/S0022-5223(98)70455-6 / J Thor Cardiovasc Surg / Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. by Mack (1998)
  425. 10.1016/S0140-6736(96)03361-2 / Lancet / Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. by Isner (1996)
  426. 10.1161/01.CIR.97.12.1114 / Circulation / Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. by Baumgartner (1998)
  427. 10.1161/01.CIR.98.25.2800 / Circulation / Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. by Losordo (1998)
  428. 10.1006/mthe.2002.0638 / Mol Ther / Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. by Makinen (2002)
  429. 10.1093/emboj/21.8.1939 / EMBO J / Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. by Dor (2002)
  430. 10.1038/74725 / Nat Med / Angiopoietin-1 protects the adult vasculature against plasma leakage. by Thurston (2000)
  431. 10.1038/nm848 / Nat Med / Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. by Cao (2003)
  432. 10.1002/jgm.392 / J Gene Med / Adenoviral VEGF-A gene transfer induces angiogenesis and promotes bone formation in healing osseous tissues. by Tarkka (2003)
  433. 10.1038/nbt1102-1067 / Nat Biotechnol / Angiogenesis inhibitors suffer new setback. by Garber (2002)
  434. 10.1038/nrc905 / Nat Rev Cancer / Clinical translation of angiogenesis inhibitors. by Kerbel (2002)
  435. 10.1172/JCI200317929 / J Clin Invest / Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. by Bergers (2003)
Dates
Type When
Created 21 years ago (Aug. 4, 2004, 2:07 p.m.)
Deposited 2 years, 4 months ago (April 29, 2023, 12:03 a.m.)
Indexed 1 hour, 22 minutes ago (Sept. 3, 2025, 2:53 a.m.)
Issued 21 years, 1 month ago (Aug. 1, 2004)
Published 21 years, 1 month ago (Aug. 1, 2004)
Published Online 8 years, 10 months ago (Oct. 31, 2016)
Published Print 21 years, 1 month ago (Aug. 1, 2004)
Funders 0

None

@article{Ferrara_2004, title={Vascular Endothelial Growth Factor: Basic Science and Clinical Progress}, volume={25}, ISSN={1945-7189}, url={http://dx.doi.org/10.1210/er.2003-0027}, DOI={10.1210/er.2003-0027}, number={4}, journal={Endocrine Reviews}, publisher={The Endocrine Society}, author={Ferrara, Napoleone}, year={2004}, month=aug, pages={581–611} }